Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.
| Quantity | Price per voucher |
|---|---|
| 1+ | $0.00 |
| Q&A Session Schedule |
| 2024 Q&A |
| Chaper 1: Introduction |
| FDA Overview by Maria Oyaski | ||
| Regulatory Authority Meetings by Kevin Barber | ||
| CMC by Timothy Reinhardt |
| Chapter 2: Early Development |
| Nonclinical Development and GLPs by Brenda Faiola | ||
| GCP by David Jensen | ||
| Clinical Protocols by Ben Vaughn and Jamie Chang | ||
| Combination Products by Judy Hauser |
| Chapter 3: Regulatory Procedural |
| IND-CTA-CTx by Karl Whitney | ||
| Peds & Orphan Products by Nasrin Habibi | ||
| Marketing Applications by Sheila Plant |
| Chapter 4: Specific Product Types |
| Pharmaceuticals by Catherine Maher | ||
| Biologics and Biosimilars by Maria Oyaski | ||
| Advanced Medicinal Therapeutic Products by Maria Oyaski |
| Chapter 5: Late Development |
| Pharmacovigilance by Lisa Hornick | ||
| Product Labeling by Joseph Watson | ||
| Compliance and Inspections by Drew Barlow | ||
| Post-Marketing by Karin McIntosh |